Final Results of National Institute of Allergy and Infectious Diseases’ ACTT-1 Trial Published in New England Journal of Medicine Expand Clinical Benefits of Veklury® (remdesivir) for the Treatment of COVID-19
FOSTER CITY, Calif.–(BUSINESS WIRE)–Oct. 8, 2020– The New England Journal of ...